112 related articles for article (PubMed ID: 30774409)
1. Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma.
Ali LH; Higazi AM; Moness HM; Farag NM; Saad ZM; Moukareb HA; Soliman W; El Sagheer G; Abd El Hamid SR; Abdl Hamid H
Clin Exp Gastroenterol; 2019; 12():51-66. PubMed ID: 30774409
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the diagnostic value of alpha-l-fucosidase, alpha-fetoprotein and thymidine kinase 1 with ROC and logistic regression for hepatocellular carcinoma.
Zhang SY; Lin BD; Li BR
FEBS Open Bio; 2015; 5():240-4. PubMed ID: 25870783
[TBL] [Abstract][Full Text] [Related]
3. Serum human endothelial cell-specific molecule-1 (endocan) and vascular endothelial growth factor in cirrhotic HCV patients with hepatocellular carcinoma as predictors of mortality.
Youssef AA; Issa HA; Omar MZ; Behiry EG; Elfallah AA; Hasaneen A; Darwish M; Ibrahim DB
Clin Exp Gastroenterol; 2018; 11():431-438. PubMed ID: 30538523
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Diagnostic Efficiency of Alpha-Fetoprotein in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Single-Center Experience.
Mehinovic L; Islamagic E; Husic-Selimovic A; Kurtovic-Kozaric A; Vukobrat-Bijedic Z; Suljevic D
Open Access Maced J Med Sci; 2018 Sep; 6(9):1668-1673. PubMed ID: 30337985
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of serum STIP1 in HCC and AFP-negative HCC.
Sun H; Liu N; Lou J
Lab Med; 2024 May; ():. PubMed ID: 38780206
[TBL] [Abstract][Full Text] [Related]
6. Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating Computational Biology and Clinical Validation.
Dabbish AM; Abdelzaher HM; Abohawya M; Shamma S; Mahmoud YH; Maged A; Manaa M; Hassany M; Kobeissy F; Bazgir O; El-Fawal H; Azzazy HME; Abdelnaser A
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804809
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-41: a novel serum marker for the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma.
Li Y; Wang H; Ren D; Li J; Mu Z; Li C; He Y; Zhang J; Fan R; Yin J; Su J; He Y; Yao B
Front Oncol; 2024; 14():1408584. PubMed ID: 38835390
[TBL] [Abstract][Full Text] [Related]
8. Bio-diagnostic performances of microRNAs set related to DNA damage response pathway among hepatitis C virus-associated hepatocellular carcinoma patients.
Abdo SM; Shousha WG; Mohamed AA; Elshobaky M; Saleh M; Ali MMA
J Genet Eng Biotechnol; 2023 Aug; 21(1):85. PubMed ID: 37587273
[TBL] [Abstract][Full Text] [Related]
9. Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients.
Othman MS; Aref AM; Mohamed AA; Ibrahim WA
ISRN Hepatol; 2013; 2013():412317. PubMed ID: 27335826
[TBL] [Abstract][Full Text] [Related]
10. F-box protein 43 promoter methylation as a novel biomarker for hepatitis B virus-associated hepatocellular carcinoma.
Zhang Y; Wang JW; Su X; Li JE; Wei XF; Yang JR; Gao S; Fan YC; Wang K
Front Microbiol; 2023; 14():1267844. PubMed ID: 38029156
[TBL] [Abstract][Full Text] [Related]
11. Prospective Analysis of Squamous Cell Carcinoma Antigen-1 and -2 for Diagnosing Sinonasal Inverted Papilloma.
Hirakawa H; Ikegami T; Toyama M; Ooshiro Y; Higa T; Kinjyo H; Kondo S; Kise N; Yamashita Y; Suzuki M
J Clin Med; 2024 May; 13(9):. PubMed ID: 38731250
[No Abstract] [Full Text] [Related]
12. High pretreatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinoma.
Czauderna C; Schmidtmann I; Koch S; Pilz L; Heinrich S; Otto G; Mittler J; Lang H; Kloeckner R; Düber C; Sprinzl MF; Worns MA; Galle PR; Marquardt JU; Weinmann A
United European Gastroenterol J; 2021 Mar; ():. PubMed ID: 33709539
[TBL] [Abstract][Full Text] [Related]
13. High pre-treatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinoma.
Czauderna C; Schmidtmann I; Koch S; Pilz L; Heinrich S; Otto G; Mittler J; Lang H; Kloeckner R; Düber C; Sprinzl MF; Wörns MA; Galle PR; Marquardt JU; Weinmann A
United European Gastroenterol J; 2020 Nov; 9(3):2050640620972611. PubMed ID: 33226301
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of SCAND3 and Myo1g Gene Are Potential Diagnostic Biomarkers for Hepatocellular Carcinoma.
Xu F; Zhang L; Xu Y; Song D; He W; Ji X; Shao J
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824823
[TBL] [Abstract][Full Text] [Related]
15. The role of BCL9 genetic variation as a biomarker for hepatitis C-related hepatocellular carcinoma in Egyptian patients.
Abbas EAER; Barakat AB; Hassany M; Youssef SS
J Genet Eng Biotechnol; 2022 Jan; 20(1):4. PubMed ID: 34978646
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Mir-224, Mir-215 and Mir-143 as Serum Biomarkers for HCV Associated Hepatocellular Carcinoma.
Mamdouh S; Khorshed F; Aboushousha T; Hamdy H; Diab A; Seleem M; Saber M
Asian Pac J Cancer Prev; 2017 Nov; 18(11):3167-3171. PubMed ID: 29172295
[TBL] [Abstract][Full Text] [Related]
17. Serum LINC00152 and UCA1 in HCV-Induced Hepatocellular Carcinoma: Clinical Significance and Prognostic Value.
Shehab-Eldeen S; Essa A; Arafat ES; Sleem AS; Alhosary AA; Darwish E; Essa A; Al-Omair OA; Al-Khoufi EA; Al Abdulqader AK; Nada A
Biologics; 2023; 17():137-149. PubMed ID: 37854341
[TBL] [Abstract][Full Text] [Related]
18. The Potential Role of Circulating Long Miscellaneous RNAs in the Diagnosis and Prognosis of Hepatitis C Related Hepatocellular Carcinoma.
Abdelsattar S; Fahim SA; Kamel HFM; Al-Amodi H; Kasemy ZA; Khalil FO; Abdallah MS; Bedair HM; Gadallah AA; Sabry A; Sakr MA; Selim M; Gayed EMAE
Noncoding RNA; 2023 Oct; 9(5):. PubMed ID: 37888208
[TBL] [Abstract][Full Text] [Related]
19. Endotrophin, a pro-peptide of Type VI collagen, is a biomarker of survival in cirrhotic patients with hepatocellular carcinoma.
Leeming DJ; Nielsen SH; Vongsuvanh R; Uchila P; Nielsen MJ; Reese-Petersen AL; van der Poorten D; Eslam M; Schuppan D; Karsdal MA; George J
Hepat Oncol; 2020 Dec; 8(2):HEP32. PubMed ID: 34084451
[TBL] [Abstract][Full Text] [Related]
20. Quantitative mass spectrometric analysis of hepatocellular carcinoma biomarker alpha-fetoprotein.
Chen CC; Huang HW; Chen BR; Wong CH
RSC Chem Biol; 2023 Nov; 4(12):1073-1081. PubMed ID: 38033722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
